Cybin Inc
Change company Symbol lookup
Select an option...
CYBN Cybin Inc
BLUE bluebird bio Inc
ENSV Enservco Corp
ULIHF United Laboratories International Holdings Ltd
ABOIF Aboitiz Equity Ventures Inc
VYNE Vyne Therapeutics Inc
CEAD CEA Industries Inc
BFRI Biofrontera Inc
ARW Arrow Electronics Inc
SF-B Stifel Financial Corp
Go


Based in Canada
Company profile

Cybin Inc. is a Canada-based biopharmaceutical company, working with a network of partners and scientists to create therapeutics for patients to address a multitude of mental health issues. The Company operates in Canada, the United States, United Kingdom and Ireland. The Company is focused on progressing psychedelics to therapeutics by engineering drug discovery platforms, drug delivery systems, formulation approaches and treatment regimens for mental health disorders. The Company’s products in pipeline include EMBARK, Kernel Flow, CYB003 (Deuterated Psilocybin Analog), CYB004 (Deuterated Dimethyltryptamine), and CYB005 (Phenethylamine Derivative). EMBARK is a Psilocybin for mental distress in frontline healthcare workers. Its subsidiaries include Cybin Corp., Natures Journey Inc., Serenity Life Sciences Inc., Cybin US Holdings Inc., Adelia Therapeutics Inc. and Cybin IRL Limited.

Price
Delayed
$0.5858
Day's Change
0.0228 (4.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.62
Day's Low
0.545
Volume
(Average)

Today's volume of 393,667 shares is on pace to be in-line with CYBN's 10-day average volume of 511,483 shares.

393,667
  • Prev Close
    0.563
  • Today's Open
    0.60
  • Day's Range
    0.545-0.62
  • Avg Vol (10-day)
    511.5K
  • Last (time)
    2:50p ET 07/05/22
  • Last (size)
    100
  • 52-Wk Range
    0.3903 - 3.38
    LowHigh
  • (08/02/21 - 05/13/22)
    50.09%
  • 80.1%
  • Market Cap
    97.9M
  • Shares Outstanding
    167.1M
  • -0.40
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 10.79
  • (% of float 06/15/22)
    2.19

Latest News

June 27, 2022
7:29 pm ET
BusinessWire
8:00 am ET
BusinessWire
June 22, 2022
7:30 am ET
BusinessWire
June 16, 2022
8:00 am ET
BusinessWire
June 15, 2022
8:50 am ET
PR Newswire
June 09, 2022
4:01 pm ET
BusinessWire
June 07, 2022
8:00 am ET
BusinessWire
June 03, 2022
6:18 pm ET
BusinessWire
8:00 am ET
BusinessWire
June 02, 2022
4:01 pm ET
BusinessWire
8:00 am ET
BusinessWire
May 31, 2022
8:00 am ET
BusinessWire
May 17, 2022
8:00 am ET
BusinessWire
May 11, 2022
8:00 am ET
BusinessWire
May 09, 2022
4:22 pm ET
BusinessWire
9:00 am ET
BusinessWire
May 05, 2022
8:00 am ET
BusinessWire
April 22, 2022
8:00 am ET
BusinessWire
April 21, 2022
8:50 am ET
PR Newswire
8:00 am ET
BusinessWire
April 13, 2022
3:42 pm ET
Accesswire
8:55 am ET
PR Newswire
8:00 am ET
BusinessWire
April 08, 2022
8:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.